Tested Applications
| Positive WB detected in | MOLT-4 cells, NK-92 cells, Jurkat cells |
| Positive IHC detected in | human tonsillitis tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:1000-1:4000 |
| Immunohistochemistry (IHC) | IHC : 1:50-1:500 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
21448-1-AP targets PVRIG in WB, IHC, IF, ELISA applications and shows reactivity with human samples.
| Tested Reactivity | human |
| Cited Reactivity | human |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag13815 Product name: Recombinant human PVRIG protein Source: e coli.-derived, PET28a Tag: 6*His Domain: 193-326 aa of BC001129 Sequence: LRRHKHRPAPRLQPSRTSPQAPRARAWAPSQASQAALHVPYATINTSCRPATLDTAHPHGGPSWWASLPTHAAHRPQGPAAWASTPIPARGSFVSVENGLYAQAGERPPHTGPGLTLFPDPRGPRAMEGPLGVR Predict reactive species |
| Full Name | poliovirus receptor related immunoglobulin domain containing |
| Calculated Molecular Weight | 326 aa, 34 kDa |
| Observed Molecular Weight | ~34 kDa |
| GenBank Accession Number | BC001129 |
| Gene Symbol | PVRIG |
| Gene ID (NCBI) | 79037 |
| RRID | AB_2878859 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | Q6DKI7 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
PVRIG, also named as CD112R and C7orf15, is an immune suppressive molecule expressed on T and NK cells. It's a cell surface receptor for NECTIN2. PVRIG is a target for the treatment of cancer.
Protocols
| Product Specific Protocols | |
|---|---|
| IHC protocol for PVRIG antibody 21448-1-AP | Download protocol |
| WB protocol for PVRIG antibody 21448-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The PVRIG Polyclonal antibody (Cat# 21448-1-AP) has 1 citation to date. It was used in a study published in Cell Death & Disease (IF 12.2), investigating the spatiotemporal role of CD112/PVRIG in T-cell exhaustion and ferroptosis crosstalk in cervical cancer. The antibody was applied via immunofluorescence (IF) in human samples. The research falls within the fields of tumor immunology, cell death mechanisms, and gynecologic oncology.
| Species | Application | Title |
|---|---|---|
Cell Death Dis Spatiotemporal mapping of CD112 unveils its dichotomous role in T-cell exhaustion and ferroptosis crosstalk in cervical cancer. |







